The objective of this study was to assess clinical measurements related to the effectiveness of bisphosphonate (BP) administration as a supplement to conventional dental treatment in patients free of bone-related diseases using a network meta-analysis. Only randomized controlled trials (RCTs) were included that provided dental clinical measurements on human patients treated with BPs with or without similar untreated controls or treated with placebo. Information sources included a systematic search of 17 electronic databases up to August 2020, complemented by manual searches. Risk of bias assessment was performed with the revised Cochrane risk of bias tool for randomized trials (RoB 2.0). Extracted measurements were pooled according to time of evaluation. The random-effects model by DerSimonian and Laird was used to calculate mean differences (MDs) and the respective 95% confidence intervals (CIs). Seven RCTs were included in the network meta-analysis, assessing 391 subjects reporting on periodontal treatment effects after 2 to 12 mo of BP administration. BP treatment was associated with significant improvement of most clinical measurements, compared with BP-naive controls. According to the network ranking, alendronate was more efficient in improvement of probing depth and clinical attachment gain when compared to zoledronate or alendronate/risedronate. Similarly, the local application of alendronate as a gel was more effective than the oral administration. A long-term analysis of the pharmaceutical effects was not possible due to insufficient data. The current review, performed according to existing guidelines, included only RCTs and, through appropriate statistical analyses, provided precise estimates for most assessed outcomes. However, no adverse effects or long-term treatment results were analyzed due to inadequate pertinent data. BP administration seems to be beneficial in the short term for the treatment of periodontal diseases, mainly through controlling periodontal inflammation.
American Academy of Periodontology, Research, Science and Therapy Committee of the American Academy of Periodontology. 2000. Position paper: the role of controlled drug delivery for periodontitis. J Periodontol. 71(1):125–140.
2.
BauerJSBeckNKieferJStockmannPWichmannMEitnerS. 2012. Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg. 4(3):277–282.
3.
BeggCBMazumdarM. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50(4):1088–1101.
4.
BellerEMGlasziouPPAltmanDGHopewellSBastianHChalmersIGøtzschePCLassersonTToveyD; PRISMA for Abstracts Group. 2013. PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med. 10(4):e1001419.
5.
BorensteinMHedgesLVHigginsJPTRothsteinHR. 2009. Introduction to meta-analysis. Chichester (UK): John Wiley.
6.
BrunsvoldMAChavesESKornmanKSAufdemorteTBWoodR. 1992. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol. 63(10):825–830.
7.
CariniFSaggeseVPorcaroGBarbanoLBaldoniM. 2012. Surgical protocol in patients at risk for bisphosphonate osteonecrosis of the jaws: clinical use of serum telopetide CTX in preventive monitoring of surgical risk. Ann Stomatol (Roma). 3(1):31–36.
8.
DerSimonianRLairdN. 1986. Meta-analysis in clinical trials. Control Clin Trials. 7(3):177–188.
9.
DiasSWeltonNJCaldwellDMAdesAE. 2010. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 29(7–8):932–944.
10.
DutraBCOliveiraAMSDOliveiraPADManziFRCortelliSCCotaLOMCostaFO. 2017. Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial. J Appl Oral Sci. 25(3):310–317.
11.
DuvalSTweedieR. 2000. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 56(2):455–463.
12.
EggerMSmithDGSchneiderMMinderC. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315(7109):629–634.
13.
FerlitoSPuzzoSLiardoC. 2011. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series. J Oral Maxillofac Surg. 69(6):e1–e4.
14.
FleisherKEWelchGKottalSCraigRGSaxenaDGlickmanRS. 2010. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 110(4):509–516.
15.
GrazianiFCeiSGuerreroALa FerlaFVanoMTonettiMGabrieleM. 2009. Lack of short-term adjunctive effect of systemic neridronate in non-surgical periodontal therapy of advanced generalized chronic periodontitis: an open label-randomized clinical trial. J Clin Periodontol. 36(5):419–427.
16.
GünaldiMAfsarCUDumanBBKaraIOTatliUSahinB. 2015. Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncol Lett. 10(1):439–442.
17.
GuptaAGovilaVPantVAGuptaRVermaUPAhmadHMohanS. 2018. A randomized controlled clinical trial evaluating the efficacy of zoledronate gel as a local drug delivery system in the treatment of chronic periodontitis: a clinical and radiological correlation. Natl J Maxillofac Surg. 9(1):22–32.
18.
GuyattGHOxmanADSchünemannHTugwellPKnottnerusA. 2011. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 64(4):380–382.
19.
HigginsJPGreenS. 2011. Cochrane handbook for systematic reviews of interventions. Version 5.10 (updated March2011). The Cochrane Collaboration [accessed 2020 Apr 20]. http://www.cochrane.org/handbook.
20.
HsiaoAGlickmanGHeJ. 2009. A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates. J Endod. 35(11):1525–1528.
21.
HuttonBSalantiGCaldwellDMChaimaniASchmidCHCameronCIoannidisJPStrausSThorlundKJansenJP, et al. 2015. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 162(11):777–784.
22.
IoannidisJP. 2008. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 14(5):951–957.
23.
IpshitaSKurianIGDileepPKumarSSinghPPradeepAR. 2018. One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: a randomized, controlled clinical trial. J Investig Clin Dent. 9(3):e12334.
24.
KatoGFLopesRNJaguarGCSilvaAPAlvesFA. 2013. Evaluation of socket healing in patients undergoing bisphosphonate therapy: experience of a single Institution. Med Oral Patol Oral Cir Bucal. 18(4):e650–e656.
25.
KrahnUBinderHKönigJ. 2013. A graphical tool for locating inconsistency in network meta-analyses. BMC Med Res Methodol. 13:35.
26.
KrishnaRMaithreyiRSurapaneniKM. 2010. Research bias: a review for medical students. J Clin Diagn Res. 4(2):2320–2324.
27.
LaneNArmitageGCLoomerPHsiehSMajumdarSWangHYJeffcoatMMunozT. 2005. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol. 76(7):1113–1122.
28.
LauJIoannidisJPTerrinNSchmidCHOlkinI. 2006. The case of the misleading funnel plot. BMJ. 333(7568):597–600.
29.
LipGYLarsenTBSkjøthFRasmussenLH. 2012. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 60(8):738–746.
30.
Manzano-MorenoFJRamos-TorrecillasJDe Luna-BertosERuizCGarcía-MartínezO. 2015. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis. J Craniomaxillofac Surg. 43(3):396–401.
31.
MorelliTMossKLBeckJPreisserJSWuDDivarisKOffenbacherS. 2017. Derivation and validation of the periodontal and tooth profile classification system for patient stratification. J Periodontol. 88(2):153–165.
32.
NeedlemanIGPandyaNVSmithSRFoyleDM. 1995. The role of antibiotics in the treatment of periodontitis (part 2—controlled drug delivery). Eur J Prosthodont Restor Dent. 3(3):111–117.
33.
OliveiraPSRodriguesJAShibliJAPiattelliAIezziGPerrottiV. 2016. Influence of osteoporosis on the osteocyte density of human mandibular bone samples: a controlled histological human study. Clin Oral Implants Res. 27(3):325–328.
34.
OliveiraTCBradaschia-CorreaVCastroJRSimõesAArana-ChavezVE. 2014. Ultrastructural and biochemical analysis of the effects of alendronate on salivary glands of young rats. Arch Oral Biol. 59(12):1307–1311.
35.
O’uchiNNishikawaHYoshinoTKanohHMotoieHNishimoriEShimaokaTAbeTShikamaHFujikuraT, et al. 1998. Inhibitory effects of YM175, a bisphosphonate, on the progression of experimental periodontitis in beagle dogs. J Periodontal Res. 33(4):196–204.
36.
PapadopoulosMA. 2003. Meta-analysis in evidence-based orthodontics. Orthod Craniofac Res. 6(2):112–126.
37.
PapapoulosSE. 2008. Bisphosphonates: how do they work?Best Pract Res Clin Endocrinol Metab. 22(5):831–847.
38.
PetersJLSuttonAJJonesDRAbramsKRRushtonL. 2008. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 61(10):991–996.
39.
PradeepARKanoriyaDSinghalSGargVManoharBChatterjeeA. 2017. Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Investig Clin Dent. 8(3):12215.
40.
PradeepARKumariMRaoNSNaikSB. 2013. 1% Alendronate gel as local drug delivery in the treatment of class II furcation defects: a randomized controlled clinical trial. J Periodontol. 84(3):307–315.
41.
ReddyMSWeatherfordTWIIISmithCAWestBDJeffcoatMKJacksTM. 1995. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol. 66(3):211–217.
RochaMLMalacaraJMSánchez-MarinFJVazquez de la TorreCJFajardoME. 2004. Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial. J Periodontol. 75(12):1579–1585.
44.
RoslingBNymanSLindheJJernB. 1976. The healing potential of the periodontal tissues following different techniques of periodontal surgery in plaque-free dentitions. J Clin Periodontol. 3(4):233–250.
45.
RückerG. 2012. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 3(4):312–324.
46.
RückerGSchwarzerG. 2015. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 15:58.
47.
SalantiGDel GiovaneCChaimaniACaldwellDMHigginsJPT. 2014. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 9(7):e99682.
48.
SchellerELBaldwinCMKuoSD’SilvaNJFeinbergSEKrebsbachPHEdwardsPC. 2011. Bisphosphonates inhibit expression of p63 by oral keratinocytes. J Dent Res. 90(7):894–899.
49.
SharmaAPradeepAR. 2012a. Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial. J Periodontol. 83(1):11–18.
50.
SharmaAPradeepAR. 2012b. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial. J Periodontol. 83(1):19–26.
51.
SharmaARamanAPradeepAR. 2017. Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers. J Appl Oral Sci. 25(3):243–249.
52.
SheokandVChadhaVSPalwankarP. 2019. The comparative evaluation of 1% alendronate gel as local drug delivery system in chronic periodontitis in smokers and non-smokers: randomized clinical trial. J Oral Biol Craniofac Res. 9(2):198–203.
53.
SkrepnekGHSealBTangiralaMJeffcoatMKWattsNBHayJW. 2010. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. Gen Dent. 58(6):484–492.
54.
SterneJACSavovicJPageMJElbersRGBlencoweNSBoutronICatesCJChengHYCorbettMSEldridgeSM, et al. 2019. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 366:l4898.
55.
TsalikisLSakellariDDagalisPBouraPKonstantinidisA. 2014. Effects of doxycycline on clinical, microbiological and immunological parameters in well-controlled diabetes type-2 patients with periodontal disease: a randomized, controlled clinical trial. J Clin Periodontol. 41(10):972–980.
56.
TsoukakiMKalpidisCDSakellariDTsalikisLMikrogiorgisGKonstantinidisA. 2013. Clinical, radiographic, microbiological, and immunological outcomes of flapped vs. flapless dental implants: a prospective randomized controlled clinical trial. Clin Oral Implants Res. 24(9):969–976.
57.
VeenaHRPrasadD. 2010. Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects. J Indian Soc Periodontol. 14(1):40–45.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
